[1]
Ayats-Vidal, R. et al. 2022. Long-term outcome of omalizumab-assisted desensitisation to cow’s milk and eggs in patients refractory to conventional oral immunotherapy: real-life study. Allergologia et Immunopathologia. 50, 3 (May 2022), 1–7. DOI:https://doi.org/10.15586/aei.v50i3.537.